BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Amgen Foundation Pledges Up to $500,000 In Relief to Victims of the Southern California Wildfires

  Of this commitment, $200,000 will be directed to the United Way of Ventura County to support their immediate relief efforts.

  December 11, 2017

   · 

  6 min read
• BioCapital

  Processa Pharma Announces Reverse Stock Split and Launches New Website

  Processa formed from the merger of Promet Therapeutics and Heatwurx, is an emerging clinical stage biotech company focused on the development of drugs for the treatment of high unmet medical need conditions.

  December 11, 2017

   · 

  3 min read
• Hookipa Biotech Raises $60M (€50M) in an Oversubscribed Round C Financing

  The round was led by an undisclosed blue chip U.S. public investment fund specializing in life sciences, alongside other new investors HBM Partners, Hillhouse Capital, Sirona Capital and strategic investor Gilead.

  December 11, 2017

   · 

  3 min read
• Business

  Evotec’s Academic Bridge LAB282 With Oxford University Celebrating One Year of Impact

  Evotec announced today that LAB282, the £ 13 m drug discovery partnership between Oxford University, Oxford Sciences Innovation and Evotec, is celebrating its first year of operation after successfully accelerating 12 drug discovery and development projects at the University.

  December 11, 2017

   · 

  6 min read
• Biotech Beach

  New Release Geneious Biologics Gives Deeper Insight Into Big Data

  Geneious Biologics released major new capability that will allow developers of biological drugs to analyze millions of raw antibody sequences in minutes, accelerating identification of therapeutic antibody candidates.

  December 11, 2017

   · 

  3 min read
• Biotech Beach

  FDA Approves Investigational Device Exemption for SetPoint Bioelectronic Therapy Clinical Study in Rheumatoid Arthritis

  SetPoint has received Investigational Device Exemption (IDE) approval from the FDA to initiate a pilot trial in the U.S. for patients with drug refractory rheumatoid arthritis (RA).

  December 11, 2017

   · 

  3 min read
• Policy

  Puma Biotechnology Announces Positive Outcome of European Opposition Proceedings and OP Upheld All the Claims in the Patent

  Puma has exclusive license rights to EP 2416774 from Pfizer, Inc., the parent of patentee Wyeth LLC.

  December 11, 2017

   · 

  7 min read
• Italfarmaco Presents Positive Phase II Study Results for Givinostat in Polycythemia Vera Patients at the ASH Annual Meeting

  Italfarmaco Group today announced the positive results from two clinical trials evaluating its proprietary histone deacetylase (HDAC) inhibitor givinostat in Polycythemia Vera patients.

  December 11, 2017

   · 

  4 min read
• Biotech Beach

  Galectin Therapeutics to Webcast Corporate Update at Annual Meeting of Shareholders

  The webcast is expected to commence at approximately 9 a.m. ET on Thursday, December 14, 2017.

  December 11, 2017

   · 

  2 min read
• Biotech Beach

  Scientist.com Celebrates 10th Anniversary as Outsourcing Marketplace Leader

  Scientist.com now has more than 2,250 pre-signed global suppliers in its network, enabling researchers to custom design and purchase thousands of research services in just a few mouse clicks

  December 11, 2017

   · 

  2 min read